PATENT CLAIM ANALYSIS

Application Number: 15765232
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["548", "400000"]

Abstract:
Disclosed are compounds based on dolastatins, drug-conjugates, methods of preparing drug-conjugates, and uses thereof. Also disclosed are pharmaceutical compositions and methods of treatment. The compounds and drug-conjugates disclosed herein can be used to treat diseases such as bladder cancer, breast cancer, colon cancer, rectal cancer, endometrial cancer, kidney cancer, lung cancer, melanoma, non-Hodgkin lymphoma, glioblastoma, pancreatic cancer, prostate cancer, and thyroid cancer.

Claim (Index 60):
A method of treating cancer, comprising administering a compound of  claim 1  to a subject in need thereof, wherein the cancer is selected from the group consisting of uterine sarcoma cancer, bladder cancer, breast cancer, colon cancer, rectal cancer, endometrial cancer, kidney cancer, lung cancer, melanoma, non-Hodgkin lymphoma, glioblastoma, pancreatic cancer, prostate cancer, and thyroid cancer.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.77778
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14401318', '14843520', '15581749', '15557703', '13513982']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7512107986997902
- 35 USC 102 Novelty (BERT): 0.5121212203479757
- Combined Prediction Score: 0.7273018408646088
- Mean Citation Score: 295.580128
- Max Citation Score: 303.1212
- Similarity Product: 218.7747694009781

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test